SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject1/3/2003 8:33:33 PM
From: Jorgen Jensen  Read Replies (1) of 2001
 
GLIATECH ANNOUNCES AGREEMENT TO SELL ADCON® GEL ASSETS

Cleveland, OH— January 3, 2003 -- Gliatech Inc. (GLIAQ.PK) has entered into a definitive agreement to sell its ADCON® Gel assets to Wright Medical Group, Inc. (Nasdaq: WMGI) for $8.4 million and future royalties. Such agreement is subject to Bankruptcy Court approval, and the transaction is expected to close in the first quarter of 2003. Gliatech is conducting an auction of its ADCON® assets as part of the Company's Bankruptcy Proceedings announced May 9, 2002. The Company continues to have discussions with interested parties regarding the sale of its ADCON® Solution assets. Adams, Harkness & Hill, Inc. serves as Gliatech’s investment advisor to conduct and manage the auction of the Company’s ADCON® assets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext